P-Cresol

P-Cresol

SCHEMBL29387264

[2H]c1c([2H])c(C([2H])([2H])[2H])c([2H])c([2H])c1O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
P-Xylene SCHEMBL2137209 0.84
P-Cresol SCHEMBL17926780 0.83
P-Cresol SCHEMBL1331403 0.81
Hydroquinone SCHEMBL1332212 0.77
SCHEMBL29596392 0.71
SCHEMBL13643312 0.71
Tolyl Boronic Acid SCHEMBL29954251 0.70 CA2 (0.39)
Toluene SCHEMBL112707 0.69
SCHEMBL13916850 0.69 CA5A (0.36)
P-Cresol SCHEMBL31097133 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12163961-B2 BTEX metabolites derivatization kit and composition BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2024-12-10 US disclosed
US-20230091848-A1 DISEASE DETECTION AND TREATMENT BASED ON PHENYLACETYL GLUTAMINE LEVELS THE CLEVELAND CLINIC FOUNDATION 2023-03-23 US disclosed
US-20230069226-A1 BTEX METABOLITES DERIVATIZATION KIT AND COMPOSITION BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2023-03-02 US disclosed
EP-4100541-A1 DISEASE DETECTION AND TREATMENT BASED ON PHENYLACETYL GLUTAMINE LEVELS The Cleveland Clinic Foundation (US) 2022-12-14 EP disclosed
US-11506669-B2 BTEX metabolites derivatization kit and composition BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2022-11-22 US disclosed
US-20220050090-A1 MASS SPECTROMETRY ASSAY METHOD FOR DETECTION AND QUANTITATION OF MICROBIOTA RELATED METABOLITES METABOLON, INC. 2022-02-17 US disclosed